HLS Therapeutics Net Loss History
| HLS Stock | CAD 4.40 0.11 2.56% |
Net Loss | First Reported 2018-06-30 | Previous Quarter -2.7 M | Current Value -3.9 M | Quarterly Volatility 4.2 M |
Macro event markers
HLS Therapeutics's Net Loss sits within a range defined by its operating history and sector positioning.
Latest HLS Therapeutics' Net Loss Growth Pattern
Plotted below is HLS Therapeutics' Net Loss, tracking 11 years of reported values. The latest annual change of 4.76% continues a firming multi-year pattern. Peaks and troughs in HLS Therapeutics' Net Loss highlight where the most significant shifts occurred.
| Net Loss | 10 Years Trend |
|
Net Income Applicable To Common Shares |
| Timeline |
Net Loss Trend Statistics
| Arithmetic Mean | -12,464,641 | |
| Coefficient Of Variation | -75.10 | |
| Mean Deviation | 8,247,067 | |
| Median | -14,893,000 | |
| Standard Deviation | 9,360,378 | |
| Sample Variance | 87.6T | |
| Range | 25.7M | |
| R-Value | -0.81 | |
| Mean Square Error | 31.6T | |
| R-Squared | 0.66 | |
| Significance | 0.000071 | |
| Slope | -1,508,021 | |
| Total Sum of Squares | 1401.9T |
HLS Therapeutics Net Loss History
| 2026 | -18.6 M | ||
| 2025 | -17.7 M | ||
| 2024 | -19.7 M | ||
| 2023 | -27.5 M | ||
| 2022 | -23.6 M | ||
| 2021 | -13.1 M | ||
| 2020 | -15.3 M | ||
| 2019 | -19.6 M | ||
| 2018 | -24.8 M | ||
| 2017 | -6.1 M | ||
| 2016 | -14.9 M |
Methodology, Assumptions & Data Sources
Here is how HLS Therapeutics's Net Loss has changed over time. Year-over-year changes are the easiest way to spot turning points.
The analytics block for HLS Therapeutics relies on periodic company reporting and market reference feeds, with quality checks and normalization applied before rendering. Timing can vary by data vendor. This section presents reference data and historical patterns only and does not constitute an investment recommendation or advice.